Spero Therapeutics Receives FDA Approval for Phase 3 Clinical Trial of Tebipenem HBr
1 Mins read
Spero Therapeutics has obtained written agreement from the U.S. Food and Drug Administration (FDA) for a Special Protocol Assessment, which outlines the…